|
Arotech Reverse Stock Split
and Warrant Issuance Proposals Receive Overwhelming Approval from
Stockholders
One-for-fourteen reverse stock
split to take effect at the opening of trading on June 21 –
Arotech ticker symbol will be ARTXD from June 21 to July 19
June
19, 2006 - Arotech Corporation (NasdaqNM: ARTX) announced today
that at its annual meeting of stockholders held this morning in
New York, New York, Arotech’s stockholders overwhelmingly
approved proposals to effect a one-for-fourteen reverse split of
Arotech’s common stock, and to ratify, for purposes of NASD
Marketplace Rule 4350(i)(1)(C)(ii), the issuance in February, March
and April of 2006 of warrants expiring March 31, 2008 to purchase
up to 4,175,071 shares of Arotech’s common stock at a price
of $0.594 per share (approximately 298,220 shares after giving effect
to the reverse split).
The resolution ratifying the reverse
stock split received the support of over 88% of the total votes
cast in person and by proxy on the proposal, being a majority of
all outstanding shares of Arotech’s common stock entitled
to vote on this proposal as required by Delaware law.
The resolution ratifying the warrant
issuance received the support of over 65% of the total votes cast
in person and by proxy on the proposal.
Stockholders also overwhelmingly
re-elected directors Jay M. Eastman and Steven Esses.
The one-for-fourteen reverse stock
split will take effect the morning of Wednesday, June 21, 2006.
Pursuant to the rules of the Nasdaq Stock Market, Arotech’s
stock ticker symbol will change from ARTX to ARTXD beginning on
Wednesday, June 21 through and including Wednesday, July 19 (a period
of twenty business days). The symbol will revert back to ARTX beginning
with the opening of trading on Thursday, July 20, 2006.
“We appreciate this tremendous
stockholder support for our growth and share capital management
objectives,” said Robert S. Ehrlich, Chairman and CEO of Arotech.
“We will work hard to justify our stockholders’ confidence.”
About Arotech Corporation
Arotech Corporation is a leading
provider of quality defense and security products for the military,
law enforcement and homeland security markets, including multimedia
interactive simulators/trainers, lightweight armoring and advanced
zinc-air and lithium batteries and chargers. Arotech operates through
three major business divisions: Armor, Simulation and Training and
Battery and Power Systems.
Arotech is incorporated in Delaware,
with corporate offices in Ann Arbor, Michigan, and research, development
and production subsidiaries in Alabama, Colorado, Michigan, California
and Israel.
Except for the historical information herein,
the matters discussed in this news release include forward-looking
statements, as defined in the Private Securities Litigation Reform
Act of 1995, including Arotech’s ability to meet the conditions
set forth in the decision of the Nasdaq Listing Qualifications Panel.
The words “believes,” “anticipates,” “expects,”
“estimates” and similar expressions are intended to identify
such forward-looking statements. Forward-looking statements reflect
management’s current knowledge, assumptions, judgment and expectations
regarding future performance or events. Although management believes
that the expectations reflected in such statements are reasonable,
readers are cautioned not to place undue reliance on these forward-looking
statements, as they are subject to various risks and uncertainties
that may cause actual results to vary materially. These risks and
uncertainties include, but are not limited to, risks relating to:
the ineffectiveness of Arotech’s internal control over financial
reporting and disclosure controls and procedures; product and technology
development; the uncertainty of the market for Arotech’s products;
changing economic conditions; delay, cancellation or non-renewal,
in whole or in part, of contracts or of purchase orders; Arotech’s
ability to remain listed on the Nasdaq Stock Market in accordance
with the Nasdaq’s $1.00 minimum bid price and other continued
listing standards; dilution resulting from issuances of Arotech’s
common stock upon conversion or payment of its outstanding convertible
debt, which would be increasingly dilutive if and to the extent that
the market price of Arotech’s stock decreases; and other risk
factors detailed in Arotech’s most recent Annual Report on Form
10-K for the fiscal year ended December 31, 2005, as amended, and
other filings with the Securities and Exchange Commission. Arotech
assumes no obligation to update the information in this release. Reference
to Arotech’s website above does not constitute incorporation
of any of the information thereon into this press release.
|